This week, a piece by Laura Isensee in the Miami Herald gave readers not only an overview of the Diabetes Research Institute and its goal of finding a cure for diabetes, but the article entitled, "Diabetes researchers look at cellular-level transplants as bridge to a cure," allowed the inventor of the Ricordi Chamber, DRI's own Dr. Camillo Ricordi, to explain where things are in the matter of islet transplantation (clinical trials await FDA approval) and DRI's Dr. Cherie Stabler provided details on DRI's efforts to gather and protect islet cells from the body's immune system.

• Dr. Cherie Stabler is is an Associate Professor of Biomedical Engineering & Surgery at the University of Miami School of Medicine and Director of the Tissue Engineering Laboratory at the Diabetes Research Institute.

• Camillo Ricordi, M.D. is the Stacy Joy Goodman Professor of Surgery, Distinguished Professor of Medicine, Professor of Biomedical Engineering, and Microbiology and Immunology, and serves as Scientific Director and Chief Academic Officer of the University of Miami Diabetes Research Institute.

This article in the Miami Herald is excellent in its overview of the current state of diabetes cure research both at DRI and around the world, and gives a good explanation not only of Dr. Rircordi's contributions via the Ricordi Chamber (giving recognition to DRI's Dr. Ricordi as a global leader in diabetes research) but also in other research that compliments islet transplantation work as researchers worldwide join in the goal of finding a solution to the severe and sometime fatal problem of diabetes.